Complement associated pathogenic mechanisms in myasthenia gravis

Keyphrases

• Acetylcholine Receptor Antibody 40%
• Anti-C1q 20%
• Anti-C5 20%
• Cobra Venom Factor 20%
• Common Complement 20%
• Complement Factor C3 20%
• Complement Inhibitors 40%
• Complement Pathway 40%
• Complement Receptors 20%
• Complement System 20%
• Complex Formation 20%
• Decay Accelerating Factor 20%
• Experimental Autoimmune Myasthenia Gravis 100%
• Gene-deficient Mice 20%
• Increased Vulnerability 20%
• Knock-in Mouse Model 20%
• Membrane Attack Complex 20%
• Model Experimental 20%
• Muscle Pathology 20%
• Muscle Weakness 20%
• Myasthenia Gravis 100%
• Nerve 20%
• Novel Therapies 20%
• Pathogenic Mechanism 100%
• Pathway Activation 20%
• Therapy Method 20%

Immunology and Microbiology

• Cholinergic Receptor Antibody 40%
• Complement Component C1q 20%
• Complement Deposition 20%
• Complement Factor 20%
• Complement Inhibitor 40%
• Complement Membrane Attack Complex 20%
• Complement Receptor 1 20%
• Complement System 20%
• Complex Formation 20%
• Decay-Accelerating Factor 20%
• Experimental Autoimmune Myasthenia Gravis 100%
• Knockout Mouse 20%
• Mouse 20%
• Muscle Innervation 20%
• Myasthenia gravis 100%
• Naja 20%